Lupin Russian

Last updated: 13.02.2014

Address: Lupin Ltd House 9, Apartment 40, Street 26, Bakinskhi, Moscow – 117571,Russia

Tel: +7-095 4346408


Company description

Headquartered in Mumbai, India, Lupin Limited today is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. Dr. Desh Bandhu Gupta’s vision and dream to fight life threatening infectious diseases and manufacture drugs of highest national priority led to the formation of Lupin in the year 1968. His Vision, his inimitable commitment and verve have steered Lupin to achieving the distinction of becoming one of the fastest growing Generic players globally.

Lupin first gained recognition when it became one of the world’s largest manufacturers of Tuberculosis drugs. Over the years, the Company has moved up the value chain and has not only mastered the business of intermediates and APIs, but has also leveraged its strengths to build a formidable formulations business globally.

In FY 2011, net sales grew by 20% to INR 57,068 Mn up from INR 47,736 Mn the previous year. EBITDA margins increased to 20% and net profits grew at 27% to INR 8,626 Mn compared to INR 6,816 Mn in FY 2010. Standing on the shoulders of our past performance record, these results deliver some of the best growth numbers in the industry – 27% CAGR in Gross Sales; 32% CAGR in EBITDA and 38% CAGR in PAT, for the last 6 years.

Products and services

Formulations and APIs


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here